SB
ABBV icon

Strategic Blueprint’s AbbVie ABBV Stock Holding History

Strategic Blueprint’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Buy
9,738
+261
+3% +$56.2K 0.12% 174
2026
Q1 		$2.06M Buy
9,477
+178
+2% +$39.5K 0.12% 173
2025
Q4 		$2.12M Sell
9,299
-992
-10% -$226K 0.13% 166
2025
Q3 		$2.38M Buy
10,291
+330
+3% +$67.2K 0.1% 183
2025
Q2 		$1.85M Sell
9,961
-42
-0.4% -$7.81K 0.09% 201
2025
Q1 		$2.1M Sell
10,003
-280
-3% -$54.4K 0.11% 170
2024
Q4 		$1.83M Buy
10,283
+179
+2% +$32.9K 0.11% 168
2024
Q3 		$2M Sell
10,104
-1,232
-11% -$230K 0.12% 151
2024
Q2 		$1.94M Buy
11,336
+200
+2% +$33.1K 0.13% 144
2024
Q1 		$2.03M Buy
11,136
+686
+7% +$118K 0.14% 145
2023
Q4 		$1.62M Sell
10,450
-856
-8% -$125K 0.13% 155
2023
Q3 		$1.69M Buy
11,306
+286
+3% +$42K 0.16% 140
2023
Q2 		$1.48M Buy
11,020
+72
+0.7% +$10.6K 0.14% 147
2023
Q1 		$1.74M Buy
10,948
+812
+8% +$124K 0.18% 129
2022
Q4 		$1.64M Buy
10,136
+177
+2% +$27.1K 0.19% 127
2022
Q3 		$1.34M Buy
9,959
+807
+9% +$116K 0.16% 141
2022
Q2 		$1.4M Buy
9,152
+207
+2% +$31.6K 0.17% 133
2022
Q1 		$1.45M Sell
8,945
-817
-8% -$119K 0.17% 128
2021
Q4 		$1.32M Buy
9,762
+1,352
+16% +$160K 0.17% 135
2021
Q3 		$907K Sell
8,410
-1,037
-11% -$118K 0.14% 150
2021
Q2 		$1.06M Buy
9,447
+1,239
+15% +$140K 0.17% 126
2021
Q1 		$888K Buy
8,208
+784
+11% +$83.9K 0.19% 118
2020
Q4 		$795K Buy
7,424
+547
+8% +$52.6K 0.2% 102
2020
Q3 		$602K Buy
+6,877
New +$647K 0.19% 101
2019
Q4 		– Sell
-1,735
Closed -$131K – 93
2019
Q3 		$131K Buy
+1,735
New +$119K 0.1% 86
2019
Q1 		– Sell
-11,255
Closed -$1.04M – 72
2018
Q4 		$1.04M Buy
+11,255
New +$990K 1.51% 22

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Strategic Blueprint's ABBV Position: Q2 2026 in Review

Strategic Blueprint increased its AbbVie (ABBV) stake by 2.8% in Q2 2026, buying an estimated $56.2K and bringing the position to 9,738 shares worth $2.45M. The position accounts for 0.12% of the portfolio, ranked #174.

Strategic Blueprint first reported a position in ABBV in Q4 2018 and has held it in 26 quarters since. 2,011 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Strategic Blueprint held 9,738 shares of AbbVie worth $2.45M as of Q2 2026.
  • Strategic Blueprint bought 261 AbbVie shares in Q2 2026, an estimated $56.2K.
  • AbbVie made up 0.12% of Strategic Blueprint's portfolio in Q2 2026, its #174 holding.
  • Strategic Blueprint first reported a position in AbbVie in Q4 2018 and has held it in 26 quarters since.
  • 2,011 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Strategic Blueprint's 13F filing for Q2 2026, filed 23 Jul 2026.